Journal of virology
Journal
Overview
publication venue for
-
Recombination between feline leukemia virus subgroup B or C and endogenous env elements alters the in vitro biological activities of the viruses.
1992
-
A human cytomegalovirus prefusion-like glycoprotein B subunit vaccine elicits humoral immunity similar to that of postfusion gB in mice.
2025
-
The pseudorabies virus UL13 protein kinase triggers phosphorylation of the RNA demethylase FTO, which is associated with FTO-dependent suppression of interferon-stimulated gene expression.
2025
-
Immune restoration by TIGIT blockade is insufficient to control chronic SIV infection.
2024
-
Reactivation of Epstein-Barr Virus from Latency Involves Increased RNA Polymerase Activity at CTCF Binding Sites on the Viral Genome..
97.
2023
-
Novel Epitopes of the Influenza Virus N1 Neuraminidase Targeted by Human Monoclonal Antibodies..
96.
2022
-
Human Anti-neuraminidase Antibodies Reduce Airborne Transmission of Clinical Influenza Virus Isolates in the Guinea Pig Model..
96.
2021
-
The glycan hole area of HIV-1 envelope trimers contributes prominently to the induction of autologous neutralization.
2021
-
The NF-κB transcriptional footprint is essential for SARS-CoV-2 replication.
2021
-
Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein..
95.
2021
-
African-Lineage Zika Virus Replication Dynamics and Maternal-Fetal Interface Infection in Pregnant Rhesus Macaques..
95.
2021
-
Intranasal Nanoparticle Vaccination Elicits a Persistent, Polyfunctional CD4 T Cell Response in the Murine Lung Specific for a Highly Conserved Influenza Virus Antigen That Is Sufficient To Mediate Protection from Influenza Virus Challenge..
95.
2021
-
Selective BCL-XL Antagonists Eliminate Infected Cells from a Primary-Cell Model of HIV Latency but Not from Ex Vivo Reservoirs..
95.
2021
-
Rapid evolution of enhanced Zika virus virulence during direct vertebrate transmission chains.
2021
-
Zika virus infection induced apoptosis by modulating the recruitment and activation of pro-apoptotic protein Bax.
2021
-
Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers..
94.
2020
-
Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity..
94.
2020
-
Drug Resistance Mutation Frequency of Single-Genome Amplification-Derived HIV-1 Polymerase Genomes in the Cerebrospinal Fluid and Plasma of HIV-1-Infected Individuals under Nonsuppressive Therapy..
94.
2020
-
Shedding-Resistant HIV-1 Envelope Glycoproteins Adopt Downstream Conformations That Remain Responsive to Conformation-Preferring Ligands..
94.
2020
-
Seminal Plasma-Derived Extracellular-Vesicle Fractions from HIV-Infected Men Exhibit Unique MicroRNA Signatures and Induce a Proinflammatory Response in Cells Isolated from the Female Reproductive Tract..
94.
2020
-
Differential Vpu-Mediated CD4 and Tetherin Downregulation Functions among Major HIV-1 Group M Subtypes..
94.
2020
-
Long-Acting BMS-378806 Analogues Stabilize the State-1 Conformation of the Human Immunodeficiency Virus Type 1 Envelope Glycoproteins..
94.
2020
-
Integrated Assessment of Viral Transcription, Antigen Presentation, and CD8+ T Cell Function Reveals Multiple Limitations of Class I-Selective Histone Deacetylase Inhibitors during HIV-1 Latency Reversal..
94.
2020
-
Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits..
94.
2020
-
Neutralizing Antibody Induction by HIV-1 Envelope Glycoprotein SOSIP Trimers on Iron Oxide Nanoparticles May Be Impaired by Mannose Binding Lectin..
94.
2020
-
Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM..
94.
2020
-
SOS and IP Modifications Predominantly Affect the Yield but Not Other Properties of SOSIP.664 HIV-1 Env Glycoprotein Trimers..
94.
2019
-
Monoclonal Antibody Responses after Recombinant Hemagglutinin Vaccine versus Subunit Inactivated Influenza Virus Vaccine: a Comparative Study..
93.
2019
-
Antibody Responses Elicited by Immunization with BG505 Trimer Immune Complexes..
93.
2019
-
Replicons of a Rodent Hepatitis C Model Virus Permit Selection of Highly Permissive Cells..
93.
2019
-
Characterization of Novel Splice Variants of Zinc Finger Antiviral Protein (ZAP)..
93.
2019
-
Simian-Human Immunodeficiency Virus SHIV.CH505-Infected Infant and Adult Rhesus Macaques Exhibit Similar Env-Specific Antibody Kinetics, despite Distinct T-Follicular Helper and Germinal Center B Cell Landscapes..
93.
2019
-
Closing and Opening Holes in the Glycan Shield of HIV-1 Envelope Glycoprotein SOSIP Trimers Can Redirect the Neutralizing Antibody Response to the Newly Unmasked Epitopes..
93.
2019
-
Hemagglutinin Stalk-Reactive Antibodies Interfere with Influenza Virus Neuraminidase Activity by Steric Hindrance..
93.
2019
-
Genotypic and Mechanistic Characterization of Subtype-Specific HIV Adaptation to Host Cellular Immunity..
93.
2018
-
Broadly Reactive Human Monoclonal Antibodies Elicited following Pandemic H1N1 Influenza Virus Exposure Protect Mice against Highly Pathogenic H5N1 Challenge..
92.
2018
-
Effects of Adjuvants on HIV-1 Envelope Glycoprotein SOSIP Trimers In Vitro..
92.
2018
-
Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20..
92.
2018
-
Central Nervous System Inflammation and Infection during Early, Nonaccelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques..
92.
2018
-
Immunogenicity in Rabbits of HIV-1 SOSIP Trimers from Clades A, B, and C, Given Individually, Sequentially, or in Combination..
92.
2018
-
Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells..
92.
2018
-
High-Throughput Protein Engineering Improves the Antigenicity and Stability of Soluble HIV-1 Envelope Glycoprotein SOSIP Trimers..
91.
2017
-
Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope..
91.
2017
-
Reducing V3 Antigenicity and Immunogenicity on Soluble, Native-Like HIV-1 Env SOSIP Trimers..
91.
2017
-
Subtype-Specific Differences in Gag-Protease-Driven Replication Capacity Are Consistent with Intersubtype Differences in HIV-1 Disease Progression..
91.
2017
-
Improving the Expression and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers by Targeted Sequence Changes..
91.
2017
-
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment..
91.
2017
-
Convallatoxin-Induced Reduction of Methionine Import Effectively Inhibits Human Cytomegalovirus Infection and Replication..
90.
2016
-
HIV-1 Escape from a Peptidic Anchor Inhibitor through Stabilization of the Envelope Glycoprotein Spike..
90.
2016
-
Varicella-Zoster Virus Downregulates Programmed Death Ligand 1 and Major Histocompatibility Complex Class I in Human Brain Vascular Adventitial Fibroblasts, Perineurial Cells, and Lung Fibroblasts..
90.
2016
-
Sindbis Virus Can Exploit a Host Antiviral Protein To Evade Immune Surveillance..
90.
2016
-
B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts..
90.
2016
-
Respiratory Syncytial Virus (RSV) Pulmonary Infection in Humanized Mice Induces Human Anti-RSV Immune Responses and Pathology..
90.
2016
-
Chaperone-Assisted Protein Folding Is Critical for Yellow Fever Virus NS3/4A Cleavage and Replication..
90.
2016
-
Human Intestinal Enteroids: a New Model To Study Human Rotavirus Infection, Host Restriction, and Pathophysiology..
90.
2015
-
Influences on the Design and Purification of Soluble, Recombinant Native-Like HIV-1 Envelope Glycoprotein Trimers..
89.
2015
-
Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity..
89.
2015
-
Simian Varicella Virus Is Present in Macrophages, Dendritic Cells, and T Cells in Lymph Nodes of Rhesus Macaques after Experimental Reactivation..
89.
2015
-
Distinct Immune Responses in Resistant and Susceptible Strains of Mice during Neurovirulent Alphavirus Encephalomyelitis..
89.
2015
-
What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?.
89.
2015
-
Soluble T cell immunoglobulin mucin domain 3 is shed from CD8+ T cells by the sheddase ADAM10, is increased in plasma during untreated HIV infection, and correlates with HIV disease progression..
89.
2015
-
A native-like SOSIP.664 trimer based on an HIV-1 subtype B env gene..
89.
2015
-
High preexisting serological antibody levels correlate with diversification of the influenza vaccine response..
89.
2015
-
Increased replicative fitness can lead to decreased drug sensitivity of hepatitis C virus..
88.
2014
-
Seed sequence-matched controls reveal limitations of small interfering RNA knockdown in functional and structural studies of hepatitis C virus NS5A-MOBKL1B interaction..
88.
2014
-
HIV-1 Vpu antagonism of tetherin inhibits antibody-dependent cellular cytotoxic responses by natural killer cells..
88.
2014
-
Divergent H7 immunogens offer protection from H7N9 virus challenge..
88.
2014
-
Utility of humanized BLT mice for analysis of dengue virus infection and antiviral drug testing..
88.
2013
-
LINE-1 retrotransposable element DNA accumulates in HIV-1-infected cells..
87.
2013
-
The product of Kaposi's sarcoma-associated herpesvirus immediate early gene K4.2 regulates immunoglobulin secretion and calcium homeostasis by interacting with and inhibiting pERP1..
87.
2013
-
Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses..
87.
2013
-
Influences on trimerization and aggregation of soluble, cleaved HIV-1 SOSIP envelope glycoprotein..
87.
2013
-
Structural characterization of cleaved, soluble HIV-1 envelope glycoprotein trimers..
87.
2013
-
High-throughput sequencing reveals principles of adeno-associated virus serotype 2 integration..
87.
2013
-
Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission..
87.
2013
-
Response of hepatitis C virus to long-term passage in the presence of alpha interferon: multiple mutations and a common phenotype..
87.
2013
-
Comparison of viral Env proteins from acute and chronic infections with subtype C human immunodeficiency virus type 1 identifies differences in glycosylation and CCR5 utilization and suggests a new strategy for immunogen design..
87.
2013
-
Identification of a pegivirus (GB virus-like virus) that infects horses..
87.
2013
-
Persistent enteric murine norovirus infection is associated with functionally suboptimal virus-specific CD8 T cell responses..
87.
2013
-
Use of G-protein-coupled and -uncoupled CCR5 receptors by CCR5 inhibitor-resistant and -sensitive human immunodeficiency virus type 1 variants..
87.
2013
-
Genetic and functional characterization of the N-terminal region of the hepatitis C virus NS2 protein..
87.
2013
-
The frequency of CD127(+) hepatitis C virus (HCV)-specific T cells but not the expression of exhaustion markers predicts the outcome of acute HCV infection..
87.
2013
-
Most influenza a virions fail to express at least one essential viral protein..
87.
2013
-
Transmitted/founder and chronic HIV-1 envelope proteins are distinguished by differential utilization of CCR5..
87.
2012
-
Intersubtype differences in the effect of a rare p24 gag mutation on HIV-1 replicative fitness..
86.
2012
-
Flavivirus replication complex assembly revealed by DNAJC14 functional mapping..
86.
2012
-
Glycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin..
86.
2012
-
Broadly neutralizing immune responses against hepatitis C virus induced by vectored measles viruses and a recombinant envelope protein booster..
86.
2012
-
Serology-enabled discovery of genetically diverse hepaciviruses in a new host..
86.
2012
-
C7L family of poxvirus host range genes inhibits antiviral activities induced by type I interferons and interferon regulatory factor 1..
86.
2012
-
Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans..
86.
2012
-
Targeting HIV-1 envelope glycoprotein trimers to B cells by using APRIL improves antibody responses..
86.
2011
-
Complement-dependent lysis of influenza a virus-infected cells by broadly cross-reactive human monoclonal antibodies..
85.
2011
-
HIV-1 infection abrogates CD8+ T cell mitogen-activated protein kinase signaling responses..
85.
2011
-
Myxoma virus induces type I interferon production in murine plasmacytoid dendritic cells via a TLR9/MyD88-, IRF5/IRF7-, and IFNAR-dependent pathway..
85.
2011
-
Resistance of human immunodeficiency virus type 1 to a third-generation fusion inhibitor requires multiple mutations in gp41 and is accompanied by a dramatic loss of gp41 function..
85.
2011
-
Inhibition of p53 by adenovirus type 12 E1B-55K deregulates cell cycle control and sensitizes tumor cells to genotoxic agents..
85.
2011
-
Multiple CCR5 conformations on the cell surface are used differentially by human immunodeficiency viruses resistant or sensitive to CCR5 inhibitors..
85.
2011
-
Hepatitis C virus co-opts Ras-GTPase-activating protein-binding protein 1 for its genome replication..
85.
2011
-
Strong human endogenous retrovirus-specific T cell responses are associated with control of HIV-1 in chronic infection..
85.
2011
-
Transgenic expression of polyomavirus middle T antigen in the mouse prostate gives rise to carcinoma..
85.
2011
-
Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection..
85.
2010
-
Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virus..
84.
2010
-
Splicing diversity of the human OCLN gene and its biological significance for hepatitis C virus entry..
84.
2010
-
Host factors associated with the Sindbis virus RNA-dependent RNA polymerase: role for G3BP1 and G3BP2 in virus replication..
84.
2010
-
Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization..
84.
2010
-
Identification of a dominant negative inhibitor of human zinc finger antiviral protein reveals a functional endogenous pool and critical homotypic interactions..
84.
2010
-
Caspase 9 is essential for herpes simplex virus type 2-induced apoptosis in T cells..
84.
2010
-
Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants..
84.
2010
-
Genetic analysis of the carboxy-terminal region of the hepatitis C virus core protein..
84.
2009
-
Determinants of the hepatitis C virus nonstructural protein 2 protease domain required for production of infectious virus..
83.
2009
-
Artificial transmembrane oncoproteins smaller than the bovine papillomavirus E5 protein redefine sequence requirements for activation of the platelet-derived growth factor beta receptor..
83.
2009
-
Kinetic dependence of paramyxovirus entry inhibition..
83.
2009
-
Mutations in hepatitis C virus E2 located outside the CD81 binding sites lead to escape from broadly neutralizing antibodies but compromise virus infectivity..
83.
2009
-
Cell-specific transduction of Prdm1-expressing lineages mediated by a receptor for avian leukosis virus subgroup B..
83.
2009
-
Role of defective Oct-2 and OCA-B expression in immunoglobulin production and Kaposi's sarcoma-associated herpesvirus lytic reactivation in primary effusion lymphoma..
83.
2009
-
Adenovirus induction of IRF3 occurs through a binary trigger targeting Jun N-terminal kinase and TBK1 kinase cascades and type I interferon autocrine signaling..
83.
2009
-
Internal initiation stimulates production of p8 minicore, a member of a newly discovered family of hepatitis C virus core protein isoforms..
83.
2009
-
Cell type-specific induction and inhibition of apoptosis by Herpes Simplex virus type 2 ICP10..
83.
2008
-
Human immunodeficiency virus-specific gamma interferon enzyme-linked immunospot assay responses targeting specific regions of the proteome during primary subtype C infection are poor predictors of the course of viremia and set point..
83.
2008
-
Initial B-cell responses to transmitted human immunodeficiency virus type 1: virion-binding immunoglobulin M (IgM) and IgG antibodies followed by plasma anti-gp41 antibodies with ineffective control of initial viremia..
82.
2008
-
A dynamic view of hepatitis C virus replication complexes..
82.
2008
-
Vaccinia virus subverts a mitochondrial antiviral signaling protein-dependent innate immune response in keratinocytes through its double-stranded RNA binding protein, E3..
82.
2008
-
Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets..
82.
2008
-
Selection of T1249-resistant human immunodeficiency virus type 1 variants..
82.
2008
-
Ataxia telangiectasia-mutated damage-signaling kinase- and proteasome-dependent destruction of Mre11-Rad50-Nbs1 subunits in Simian virus 40-infected primate cells..
82.
2008
-
Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection..
82.
2008
-
Transdominant inhibition of bovine viral diarrhea virus entry..
82.
2007
-
Bovine viral diarrhea virus core is an intrinsically disordered protein that binds RNA..
82.
2007
-
Identification of residues required for RNA replication in domains II and III of the hepatitis C virus NS5A protein..
82.
2007
-
3' RNA elements in hepatitis C virus replication: kissing partners and long poly(U)..
82.
2007
-
Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection..
82.
2007
-
Protective immunity to pseudomonas aeruginosa induced with a capsid-modified adenovirus expressing P. aeruginosa OprF..
81.
2007
-
Identification of novel antipoxviral agents: mitoxantrone inhibits vaccinia virus replication by blocking virion assembly..
81.
2007
-
Alanine scanning of the hepatitis C virus core protein reveals numerous residues essential for production of infectious virus..
81.
2007
-
The C terminus of hepatitis C virus NS4A encodes an electrostatic switch that regulates NS5A hyperphosphorylation and viral replication..
81.
2007
-
Hepatitis C virus p7 and NS2 proteins are essential for production of infectious virus..
81.
2007
-
Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome..
81.
2007
-
High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein..
81.
2007
-
Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection..
81.
2007
-
Participation of rab5, an early endosome protein, in hepatitis C virus RNA replication machinery..
81.
2007
-
Superinfection exclusion in cells infected with hepatitis C virus..
81.
2007
-
Sensing infection by adenovirus: Toll-like receptor-independent viral DNA recognition signals activation of the interferon regulatory factor 3 master regulator..
81.
2007
-
Mathematical modeling of subgenomic hepatitis C virus replication in Huh-7 cells..
81.
2006
-
Neutralized adenovirus-immune complexes can mediate effective gene transfer via an Fc receptor-dependent infection pathway..
80.
2006
-
Vaccinia virus infection attenuates innate immune responses and antigen presentation by epidermal dendritic cells..
80.
2006
-
Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa..
80.
2006
-
Crystal structure of the moloney murine leukemia virus RNase H domain..
80.
2006
-
Diverse CD81 proteins support hepatitis C virus infection..
80.
2006
-
A common mechanism for cytoplasmic dynein-dependent microtubule binding shared among adeno-associated virus and adenovirus serotypes..
80.
2006
-
The NS5A protein of bovine viral diarrhea virus contains an essential zinc-binding site similar to that of the hepatitis C virus NS5A protein..
80.
2006
-
Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity..
80.
2006
-
Paramyxovirus receptor-binding molecules: engagement of one site on the hemagglutinin-neuraminidase protein modulates activity at the second site..
80.
2006
-
Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry..
80.
2006
-
Liver-directed gamma interferon gene delivery in chronic hepatitis C..
79.
2005
-
Influence of fiber detargeting on adenovirus-mediated innate and adaptive immune activation..
79.
2005
-
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1..
79.
2005
-
Activation of CD21 and CD23 gene expression by Kaposi's sarcoma-associated herpesvirus RTA..
79.
2005
-
Requirements at the 3' end of the sindbis virus genome for efficient synthesis of minus-strand RNA..
79.
2005
-
Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication..
79.
2005
-
Recombinant mouse hepatitis virus strain A59 from cloned, full-length cDNA replicates to high titers in vitro and is fully pathogenic in vivo..
79.
2005
-
Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein..
79.
2005
-
Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association..
79.
2005
-
Inhibition of parainfluenza virus type 3 and Newcastle disease virus hemagglutinin-neuraminidase receptor binding: effect of receptor avidity and steric hindrance at the inhibitor binding sites..
78.
2004
-
Emergence of a drug-dependent human immunodeficiency virus type 1 variant during therapy with the T20 fusion inhibitor..
78.
2004
-
Genetic interactions between hepatitis C virus replicons..
78.
2004
-
Hepatitis C virus core protein associates with detergent-resistant membranes distinct from classical plasma membrane rafts..
78.
2004
-
An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication..
78.
2004
-
Resolution of primary severe acute respiratory syndrome-associated coronavirus infection requires Stat1..
78.
2004
-
Cytoplasmic dynein mediates adenovirus binding to microtubules..
78.
2004
-
Long-term persistence of infection in chimpanzees inoculated with an infectious hepatitis C virus clone is associated with a decrease in the viral amino acid substitution rate and low levels of heterogeneity..
78.
2004
-
R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1..
78.
2004
-
Characterization of the mouse adeno-associated virus AAVS1 ortholog..
78.
2004
-
Cytokine-mediated downregulation of coxsackievirus-adenovirus receptor in endothelial cells..
78.
2004
-
Diverse hepatitis C virus glycoproteins mediate viral infection in a CD81-dependent manner..
78.
2004
-
PKR-dependent and -independent mechanisms are involved in translational shutoff during Sindbis virus infection..
78.
2004
-
Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins..
78.
2004
-
Insertion of green fluorescent protein into nonstructural protein 5A allows direct visualization of functional hepatitis C virus replication complexes..
78.
2004
-
CKII site in Epstein-Barr virus nuclear protein 2 controls binding to hSNF5/Ini1 and is important for growth transformation..
78.
2004
-
Lack of phenotypic and functional impairment in dendritic cells from chimpanzees chronically infected with hepatitis C virus..
78.
2004
-
Coronavirus neurovirulence correlates with the ability of the virus to induce proinflammatory cytokine signals from astrocytes and microglia..
78.
2004
-
Hierarchical targeting of subtype C human immunodeficiency virus type 1 proteins by CD8+ T cells: correlation with viral load..
78.
2004
-
Modification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responses..
78.
2004
-
Uncleaved NS2-3 is required for production of infectious bovine viral diarrhea virus..
78.
2004
-
A cis-acting replication element in the sequence encoding the NS5B RNA-dependent RNA polymerase is required for hepatitis C virus RNA replication..
78.
2004
-
CD81 is required for hepatitis C virus glycoprotein-mediated viral infection..
78.
2004
-
Selection of functional 5' cis-acting elements promoting efficient sindbis virus genome replication..
78.
2004
-
Association of adenovirus with the microtubule organizing center..
77.
2003
-
Expression of the zinc-finger antiviral protein inhibits alphavirus replication..
77.
2003
-
Human T-cell leukemia virus type 1 envelope glycoprotein gp46 interacts with cell surface heparan sulfate proteoglycans..
77.
2003
-
Development and application of a reverse genetics system for Japanese encephalitis virus..
77.
2003
-
Amphipathic helix-dependent localization of NS5A mediates hepatitis C virus RNA replication..
77.
2003
-
Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR..
77.
2003
-
Kinetics of CD4+ and CD8+ memory T-cell responses during hepatitis C virus rechallenge of previously recovered chimpanzees..
77.
2003
-
Efficient replication of hepatitis C virus genotype 1a RNAs in cell culture..
77.
2003
-
Triggering of human parainfluenza virus 3 fusion protein (F) by the hemagglutinin-neuraminidase (HN) protein: an HN mutation diminishes the rate of F activation and fusion..
77.
2003
-
Hepatitis C virus RNA synthesis in a cell-free system isolated from replicon-containing hepatoma cells..
77.
2003
-
Human immunodeficiency virus type 1 attachment, coreceptor, and fusion inhibitors are active against both direct and trans infection of primary cells..
77.
2003
-
Identification of small molecule compounds that selectively inhibit varicella-zoster virus replication..
77.
2003
-
Mutations in human parainfluenza virus type 3 hemagglutinin-neuraminidase causing increased receptor binding activity and resistance to the transition state sialic acid analog 4-GU-DANA (Zanamivir)..
77.
2003
-
The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells..
77.
2003
-
A cis-acting element that directs circular adeno-associated virus replication and packaging..
76.
2002
-
Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication..
76.
2002
-
Tissue-specific transcriptional targeting of a replication-competent retroviral vector..
76.
2002
-
Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection..
76.
2002
-
Stabilization of the soluble, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1..
76.
2002
-
The Epstein-Barr virus SM protein is functionally similar to ICP27 from herpes simplex virus in viral infections..
76.
2002
-
Inhibition of chemokine expression by adenovirus early region three (E3) genes..
76.
2002
-
Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoprotein..
76.
2002
-
Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins..
76.
2002
-
Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge..
76.
2002
-
The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120..
76.
2002
-
An NF-kappa B-dependent survival pathway protects against cell death induced by TVB receptors for avian leukosis viruses..
76.
2002
-
Molecular and immunological significance of chimpanzee major histocompatibility complex haplotypes for hepatitis C virus immune response and vaccination studies..
76.
2002
-
Mutations in the yellow fever virus nonstructural protein NS2A selectively block production of infectious particles..
76.
2002
-
Transcriptional downregulation of ORF50/Rta by methotrexate inhibits the switch of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 from latency to lytic replication..
76.
2002
-
Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal..
76.
2002
-
Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins..
76.
2002
-
Isolation and characterization of noncytopathic pestivirus mutants reveals a role for nonstructural protein NS4B in viral cytopathogenicity..
75.
2001
-
Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector..
75.
2001
-
A single amino acid alteration in the human parainfluenza virus type 3 hemagglutinin-neuraminidase glycoprotein confers resistance to the inhibitory effects of zanamivir on receptor binding and neuraminidase activity..
75.
2001
-
Efficient translation initiation is required for replication of bovine viral diarrhea virus subgenomic replicons..
75.
2001
-
Importance of the N terminus of rous sarcoma virus protease for structure and enzymatic function..
75.
2001
-
Kaposi's sarcoma-associated herpesvirus can productively infect primary human keratinocytes and alter their growth properties..
75.
2001
-
Murine coronavirus spike protein determines the ability of the virus to replicate in the liver and cause hepatitis..
75.
2001
-
Adenovirus serotype 7 retention in a late endosomal compartment prior to cytosol escape is modulated by fiber protein..
75.
2001
-
Rapid assessment of adenovirus serum neutralizing antibody titer based on quantitative, morphometric evaluation of capsid binding and intracellular trafficking: population analysis of adenovirus capsid association with cells is predictive of adenovirus infectivity..
75.
2001
-
Demyelination determinants map to the spike glycoprotein gene of coronavirus mouse hepatitis virus..
74.
2000
-
Variable-loop-deleted variants of the human immunodeficiency virus type 1 envelope glycoprotein can be stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits..
74.
2000
-
Productive replication of human adenoviruses in mouse epidermal cells..
74.
2000
-
A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure..
74.
2000
-
Determinants of syncytium formation in microglia by human immunodeficiency virus type 1: role of the V1/V2 domains..
74.
2000
-
Induction of endogenous genes following infection of human endothelial cells with an E1(-) E4(+) adenovirus gene transfer vector..
73.
1999
-
CD4-Chemokine receptor hybrids in human immunodeficiency virus type 1 infection..
73.
1999
-
Pathogenesis of chimeric MHV4/MHV-A59 recombinant viruses: the murine coronavirus spike protein is a major determinant of neurovirulence..
73.
1999
-
Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs..
73.
1999
-
Expression and use of human immunodeficiency virus type 1 coreceptors by human alveolar macrophages..
73.
1999
-
Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors..
73.
1999
-
Early region 1 transforming functions are dispensable for mammary tumorigenesis by human adenovirus type 9..
73.
1999
-
Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism..
72.
1998
-
Role of variable regions A and B in receptor binding domain of amphotropic murine leukemia virus envelope protein..
72.
1998
-
Identification of nitric oxide synthase 2 as an innate resistance locus against ectromelia virus infection..
72.
1998
-
Neutralization of human immunodeficiency virus type 1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity..
72.
1998
-
Alanine substitutions of polar and nonpolar residues in the amino-terminal domain of CCR5 differently impair entry of macrophage- and dualtropic isolates of human immunodeficiency virus type 1..
72.
1998
-
Mtv-1 superantigen trafficks independently of major histocompatibility complex class II directly to the B-cell surface by the exocytic pathway..
72.
1998
-
Genetic mapping of the cloned subgroup A avian sarcoma and leukosis virus receptor gene to the TVA locus..
72.
1998
-
Structure-function analysis of the triphosphatase component of vaccinia virus mRNA capping enzyme..
71.
1997
-
Identification of envelope protein residues required for the expanded host range of 10A1 murine leukemia virus..
71.
1997
-
Promiscuous use of CC and CXC chemokine receptors in cell-to-cell fusion mediated by a human immunodeficiency virus type 2 envelope protein..
71.
1997
-
Genetic determinant of rapid-onset B-cell lymphoma by avian leukosis virus..
71.
1997
-
Minimal truncation of the c-myb gene product in rapid-onset B-cell lymphoma..
71.
1997
-
Herpesvirus saimiri encodes a functional homolog of the human bcl-2 oncogene..
71.
1997
-
Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1..
71.
1997
-
Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation..
71.
1997
-
Enhancement of in vivo adenovirus-mediated gene transfer and expression by prior depletion of tissue macrophages in the target organ..
71.
1997
-
Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma..
70.
1996
-
Constitutive retinoid receptors expressed from adenovirus vectors that specifically activate chromosomal target genes required for differentiation of promyelocytic leukemia and teratocarcinoma cells..
70.
1996
-
Quantitative model of antibody- and soluble CD4-mediated neutralization of primary isolates and T-cell line-adapted strains of human immunodeficiency virus type 1..
70.
1996
-
Human immunodeficiency virus type 1 integrase mutants retain in vitro integrase activity yet fail to integrate viral DNA efficiently during infection..
70.
1996
-
Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae..
70.
1996
-
Protein kinase C-zeta mediates NF-kappa B activation in human immunodeficiency virus-infected monocytes..
70.
1996
-
The D1 and D12 subunits are both essential for the transcription termination factor activity of vaccinia virus capping enzyme..
69.
1995
-
A point mutation in the env gene of a murine leukemia virus induces syncytium formation and neurologic disease..
68.
1994
-
The receptor for the subgroup A avian leukosis-sarcoma viruses binds to subgroup A but not to subgroup C envelope glycoprotein..
68.
1994
-
Phosphatidylcholine hydrolysis activates NF-kappa B and increases human immunodeficiency virus replication in human monocytes and T lymphocytes..
67.
1993
-
Intracerebral hemorrhages and syncytium formation induced by endothelial cell infection with a murine leukemia virus..
67.
1993
-
Isolation of a chicken gene that confers susceptibility to infection by subgroup A avian leukosis and sarcoma viruses..
67.
1993
-
Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro..
66.
1992
-
A monoclonal antibody to CD4 domain 2 blocks soluble CD4-induced conformational changes in the envelope glycoproteins of human immunodeficiency virus type 1 (HIV-1) and HIV-1 infection of CD4+ cells..
66.
1992
-
Both substrate and target oligonucleotide sequences affect in vitro integration mediated by human immunodeficiency virus type 1 integrase protein produced in Saccharomyces cerevisiae..
66.
1992
-
NF-IL6, a member of the C/EBP family, regulates E1A-responsive promoters in the absence of E1A..
66.
1992
-
Woodchuck hepatitis virus is a more efficient oncogenic agent than ground squirrel hepatitis virus in a common host..
65.
1991
-
Adenovirus E1A and E1B genes are regulated posttranscriptionally in human lymphoid cells..
64.
1990
-
Effects of insertional and point mutations on the functions of the duck hepatitis B virus polymerase..
64.
1990
-
Moloney murine leukemia virus integration protein produced in yeast binds specifically to viral att sites..
64.
1990
-
Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody..
64.
1990
-
The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope..
64.
1990
-
Passive immunity to fatal reovirus serotype 3-induced meningoencephalitis mediated by both secretory and transplacental factors in neonatal mice..
64.
1990
-
Sindbis virus ts103 has a mutation in glycoprotein E2 that leads to defective assembly of virions..
63.
1989
-
Nucleotide sequence and distinctive characteristics of the env gene of endogenous feline leukemia provirus..
63.
1989
-
Mapping of RNA- temperature-sensitive mutants of Sindbis virus: complementation group F mutants have lesions in nsP4..
63.
1989
-
A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner..
63.
1989
-
Latent herpes simplex virus type 1 transcription in human trigeminal ganglia..
62.
1988
-
Model for studying virus attachment: identification and quantitation of Epstein-Barr virus-binding cells by using biotinylated virus in flow cytometry..
62.
1988
-
Latent herpes simplex virus type 1 transcripts in peripheral and central nervous system tissues of mice map to similar regions of the viral genome..
62.
1988
-
Expression of the precore region of an avian hepatitis B virus is not required for viral replication..
61.
1987
-
In vitro recombinants of ground squirrel and woodchuck hepatitis viral DNAs produce infectious virus in squirrels..
61.
1987
-
An aberrant avian leukosis virus provirus inserted downstream from the chicken c-myc coding sequence in a bursal lymphoma results from intrachromosomal recombination between two proviruses and deletion of cellular DNA..
61.
1987
-
Retroviral DNA integrated during infection by an integration-deficient mutant of murine leukemia virus is oligomeric..
61.
1987
-
Productive infection of cultured human lymphoid cells by adenovirus..
61.
1987
-
The preS1 protein of hepatitis B virus is acylated at its amino terminus with myristic acid..
61.
1987
-
5'-terminal sequences influence the segregation of ground squirrel hepatitis virus RNAs into polyribosomes and viral core particles..
61.
1987
-
Antibodies to pre-S and X determinants arise during natural infection with ground squirrel hepatitis virus..
60.
1986
-
Expression of Sindbis virus structural proteins via recombinant vaccinia virus: synthesis, processing, and incorporation into mature Sindbis virions..
56.
1985
-
Nucleotide sequence of an infectious molecularly cloned genome of ground squirrel hepatitis virus..
51.
1984
-
Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization..
51.
1984
-
Phosphorylation of the ribosomal protein S6 is elevated in cells transformed by a variety of tumor viruses..
50.
1984
-
Transcription of the hepatitis B surface antigen gene in cultured murine cells initiates within the presurface region..
50.
1984
-
Closed circular viral DNA and asymmetrical heterogeneous forms in livers from animals infected with ground squirrel hepatitis virus..
48.
1983
-
Nucleotide sequencing of an apparent proviral copy of env mRNA defines determinants of expression of the mouse mammary tumor virus env gene..
47.
1983
-
Biological characterization of acute infection with ground squirrel hepatitis virus..
44.
1982
-
Virion DNA of ground squirrel hepatitis virus: structural analysis and molecular cloning..
44.
1982
-
Structure of a replication intermediate in the synthesis of Rous sarcoma virus DNA in vivo..
42.
1982
-
Nucleotide sequence of the 5' noncoding region and part of the gag gene of Rous sarcoma virus..
41.
1982
-
The leader sequence of the subgenomic mRNA's of Rous sarcoma virus is approximately 390 nucleotides..
41.
1982
-
Dexamethasone induction of the intracellular RNAs of mouse mammary tumor virus..
40.
1981
-
Proposal for naming host cell-derived inserts in retrovirus genomes..
40.
1981
-
Purification and translation of murine mammary tumor virus mRNA's..
39.
1981
-
Synthesis of plus strands of retroviral DNA in cells infected with avian sarcoma virus and mouse mammary tumor virus..
37.
1981
-
Molecular cloning and characterization of avian sarcoma virus circular DNA molecules..
36.
1980
-
Proviruses of mouse mammary tumor virus in normal and neoplastic tissues from GR and C3Hf mouse strains..
35.
1980
-
Organization of mouse mammary tumor virus-specific DNA endogenous to BALB/c mice..
32.
1979
-
Structural analysis of the intracellular RNAs of murine mammary tumor virus..
30.
1979
-
env Gene of chicken RNA tumor viruses: extent of conservation in cellular and viral genomes..
27.
1978
-
Virus-specific DNA in the cytoplasm of avian sarcoma virus-infected cells is a precursor to covalently closed circular viral DNA in the nucleus..
25.
1978
-
Purification of DNA complementary to the env gene of avian sarcoma virus and analysis of relationships among the env genes of avian leukosis-sarcoma viruses..
21.
1977
-
RNA complementary to the genome of RNA tumor viruses in virions and virus-producing cells..
20.
1976
-
Unintegrated viral DNA is synthesized in the cytoplasm of avian sarcoma virus-transformed duck cells by viral DNA polymerase..
18.
1976
-
Use of alkaline sucrose gradients in a zonal rotor to detect integrated and unintegrated avian sarcoma virus-specific DNA in cells..
18.
1976
-
Use of DNA-DNA annealing to detect new virus-specific DNA sequences in chicken embryo fibroblasts after infection by avian sarcoma virus..
14.
1974
-
Retraction. Moloney murine leukemia virus integration protein produced in yeast binds specifically to viral att sites..
65.
1991
-
COVID-19 Vaccines: "Warp Speed" Needs Mind Melds, Not Warped Minds.
2020
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)